Tuesday
SESSION 12: IN HONOR OF ROBERT B. RUTHERFORD, MD: NEW DEVELOPMENTS IN THE TREATMENT OF LOWER EXTREMITY ISCHEMIA; CLI, STENTS AND DEBs
SESSION 12 SCHEDULE
FOR SFA AND POPLITEAL LESIONS
9:48 AM - 9:53 AM Update On The Efficacy Of DEBs For SFA And Popliteal Artery Lesions: Why Some Trials Are Positive And Some Negative: Are Good Results Holding Up: GLOBAL IN.PACT Registry Results In >1400 Patients
  Presenter(s):Gunnar Tepe, MD / Dierk Scheinert, MD  
  View Abstract      
9:54 AM - 9:59 AM POBA And “Vanella” Bare Metal Stents (BMS) Have Merit In Some AK And BK Occlusive Lesions Reserving The Fancy And Costly Stuff For Special Situations
  Presenter(s):Iris Baumgartner, MD  
  View Abstract      
10:00 AM - 10:05 AM What Have We In The US Learned From Our European Colleagues About CLI Treatment That Can Be Used To Improve Patient Care In The US
  Presenter(s):Craig M. Walker, MD  
  View Abstract      
10:06 AM - 10:11 AM Stenting For Femoral And Popliteal Artery Lesions: Where Do We Currently Stand And What Problems Remain
  Presenter(s):Erich Minar, MD  
  View Abstract      
10:12 AM - 10:17 AM Role Of DEBs vs. DESs For SFA Lesions And Value Of Paclitaxel DEBs For Long SFA Lesions: Is There Level 1 Proof Of Benefit
  Presenter(s):Thomas Zeller, MD  
  View Abstract      
10:18 AM - 10:23 AM Paclitaxel Coated DEBs Are Better Than Uncoated Balloons In The SFA: 1-Year Results From The IN.PACT SFA I/II RCTs
  Presenter(s):Peter A. Schneider, MD / John R. Laird, MD / Gunnar Tepe, MD  
  View Abstract      
10:24 AM - 10:29 AM DEBs Are Effective For SFA Lesions: 1-Year Results From The LEVANT II RCT Show It To Be So With The Bard Lutonix DEB: Stents Were Rarely Needed
  Presenter(s):Kenneth Rosenfield, MD / Dierk Scheinert, MD  
  View Abstract      
10:30 AM - 10:35 AM Durability Of Paclitaxel Coated DEBs In The SFA: Long-Term (3-Year) Results Of The PACIFIER Trial
  Presenter(s):Michael Werk, MD  
  View Abstract      
10:36 AM - 10:41 AM Mid-Term Results From The Belgian IN.PACT Trial Of Paclitaxel Coated DEBs vs. POBA: What Is Special About This Trial
  Presenter(s):Erik E. Debing, MD, PhD  
  View Abstract      
10:42 AM - 10:50 AM Panel Discussion
FOR BK AND INFRAPOPLITEAL LESIONS
Moderator(s): Michael S. Conte, MD / George H. Meier III, MD  
10:50 AM - 10:55 AM How Often After Tibial Interventions For CLI Are Reinterventions Required: We Need Better Primary Treatments: What Are The Cost Implications
  Presenter(s):Nicolas A. Diehm, MD / Iris Baumgartner, MD  
  View Abstract      
10:56 AM - 11:01 AM Single Center RCT Of IN.PACT Deep Paclitaxel Coated DEBs vs. Uncoated Balloons Shows Benefit For BK Lesions Causing CLI: 3-Year Results Of The DEBATE Trial
  Presenter(s):Francesco Liistro, MD  
  View Abstract      
11:02 AM - 11:07 AM Single Center Results With Paclitaxel Coated DEBs For Infrapopliteal Lesions Shows Benefits: What Are They
  Presenter(s):Andrej Schmidt, MD / Dierk Scheinert, MD  
  View Abstract      
11:08 AM - 11:13 AM A Multicenter RCT (IN.PACT DEEP) Comparing Paclitaxel Coated DEBs With Uncoated Balloons Fails To Show Benefit For The DEBs
  Presenter(s):Thomas Zeller, MD  
  View Abstract      
11:14 AM - 11:19 AM Why Do The SINGLE CENTER Trial And Other BK DEB Results Differ From The Multicenter Trial Results: All DEBs Are Not Equal Or Used Equally: A Critical Analysis Of All Data And Some 3-Year Results
  Presenter(s):Francesco Liistro, MD  
  View Abstract      
11:20 AM - 11:25 AM How To Explain Differing Results Of RCTs Of DEBs In BK And Infrapopliteal Lesions: When Will We Get DEBs For BK Lesions In The US
  Presenter(s):Krishna J. Rocha-Singh, MD  
  View Abstract      
11:26 AM - 11:31 AM DEBs: Are They A Breakthrough Technology Or Another Tool In The Box: Why Is There Still Uncertainty: Do The PACUBA Trial Results With SFA/POP In Stent Restenosis (ISR) Help
  Presenter(s):Johannes Lammer, MD  
  View Abstract      
11:32 AM - 11:37 AM How Long Is Restored Patency Needed In CLI Patients; What Leads To Increased Limb Salvage With Poor Patency: Importance Of Reintervention, DESs And DEBs
  Presenter(s):Frank E.G. Vermassen, MD, PhD  
  View Abstract      
11:38 AM - 11:43 AM How Important To Interventional Outcomes Is Leaving No Foreign Body Or Metal Behind In The Artery: How Can It Be Achieved
  Presenter(s):Giancarlo Biamino, MD, PhD / Dierk Scheinert, MD  
  View Abstract      
11:44 AM - 11:49 AM Variable And High Total Costs For Caring For CLI Patients: What Can Be Done To Cut Costs Without Impairing Patient Care
  Presenter(s):Timothy M. Sullivan, MD  
  View Abstract      
11:50 AM - 12:00 PM Panel Discussion
12:00 PM - 1:00 PM Lunch Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 12
previous next